Skip to main content

Peer Review reports

From: A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO)

Original Submission
14 Mar 2022 Submitted Original manuscript
2 May 2022 Author responded Author comments - Charbel Elias
Resubmission - Version 2
2 May 2022 Submitted Manuscript version 2
17 Jun 2022 Reviewed Reviewer Report
2 Sep 2022 Reviewed Reviewer Report
29 Sep 2022 Author responded Author comments - Charbel Elias
Resubmission - Version 3
29 Sep 2022 Submitted Manuscript version 3
29 Oct 2022 Reviewed Reviewer Report
22 Nov 2022 Author responded Author comments - Charbel Elias
Resubmission - Version 4
22 Nov 2022 Submitted Manuscript version 4
Publishing
24 Nov 2022 Editorially accepted
12 Dec 2022 Article published 10.1186/s12885-022-10373-1

You can find further information about peer review here.

Back to article page